US Patent 8822754 Ecdysone receptor-based inducible gene expression system
Patent 8822754 was granted and assigned to Intrexon Corporation on September, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Dean Ervin Cress0
Marianna Zinovjevna Kapitskaya0
Subba Reddy Palli0
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08822754 Ecdysone receptor-based inducible gene expression system US Patent 8822754 Ecdysone receptor-based inducible gene expression system
Infobox
Patent Number
088227540
Patent Number
88227540
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088227540
Date of Patent
September 2, 2014
0Patent Application Number
134635270
Date Filed
May 3, 2012
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08822754 Ecdysone receptor-based inducible gene expression system
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08822754
Date of patent
September 2, 2014
Patent application number
13463527
Date Filed
May 3, 2012
Patent primary examiner
Find more entities like US Patent 8822754 Ecdysone receptor-based inducible gene expression system
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
